1661 – 1670 of 2264
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Monitoring patients treated with anti-TNF- biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies
(
- Contribution to journal › Article
-
Mark
Incidence and predictors of severe extra-articular disease manifestations in an early rheumatoid arthritis inception cohort
(
- Contribution to journal › Letter
-
Mark
T cell responses to a non-glycosylated epitope predominate in type II collagen-immunised HLA-DRB1*0101 transgenic mice
(
- Contribution to journal › Article
-
Mark
Complement deficiencies and systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Behandling af reumatoid artrit med anti-tumornekrosefaktor-alpha-antistof. Individuel monitorering af biotilgaengelighed og immunogenicitet-- sekundaerpublikation
(
- Contribution to journal › Article
-
Mark
Relapse of skin thickening after discontinuation or decrease of azathioprine therapy in a patient with diffuse cutaneous systemic sclerosis
(
- Contribution to journal › Letter
-
Mark
alpha1-Antitrypsin regulates CD14 expression and soluble CD14 levels in human monocytes in vitro.
(
- Contribution to journal › Article
-
Mark
Trends in medication and health-related quality of life in a population-based rheumatoid arthritis register in Malmo, Sweden
(
- Contribution to journal › Article
-
Mark
Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency.
(
- Contribution to journal › Article
-
Mark
Autoimmune responses against the apo B-100 LDL receptor-binding site protect against arterial accumulation of lipids in LDL receptor deficient mice.
(
- Contribution to journal › Article